Common Contracts
3 similar Convertible Promissory Note contracts by NightHawk Biosciences, Inc., Scorpius Holdings, Inc.
AMENDED AND RESTATED CONVERTIBLE PROMISSORY NOTEConvertible Promissory Note • May 2nd, 2024 • Scorpius Holdings, Inc. • Pharmaceutical preparations • Delaware
THIS AMENDED AND RESTATED CONVERTIBLE PROMISSORY NOTE (the “Note”) is issued by Scorpius Holdings, Inc. (formerly known as NightHawk Biosciences, Inc.), a Delaware corporation (the “Company”). This Note amends and restates the Convertible Promissory Note, dated January 26, 2024, issued by the Company to Holder (as defined below).
CONVERTIBLE PROMISSORY NOTEConvertible Promissory Note • January 30th, 2024 • NightHawk Biosciences, Inc. • Pharmaceutical preparations • Delaware
FOR VALUE RECEIVED, the Company promises to pay to Elusys Holdings Inc. or its registered assigns (the “Holder”), the principal amount of Two Million Two Hundred Fifty Thousand Dollars ($2,250,000) (“Principal Amount”) together with simple interest on the outstanding Principal Amount at a rate of 1% per annum until paid in full or converted. Interest shall be computed on the basis of a year of 365 days for the actual number of days elapsed. Unless earlier converted into Common Stock as provided in this Note, all payments of interest and principal under the Note shall be in lawful money of the United States of America. This Note is subject to the following additional provisions:
Convertible PROMISSORY NOTEConvertible Promissory Note • December 12th, 2023 • NightHawk Biosciences, Inc. • Pharmaceutical preparations • Delaware
FOR VALUE RECEIVED, the Company promises to pay to Elusys Holdings Inc. or its registered assigns (the “Holder”), the principal amount of Two Million, Two Hundred Fifty Thousand Dollars ($2,250,000) (“Principal Amount”) together with simple interest on the outstanding Principal Amount at a rate of 1% per annum until paid in full or converted. Interest shall be computed on the basis of a year of 365 days for the actual number of days elapsed. Unless earlier converted into Common Stock as provided in this Note, all payments of interest and principal under the Note shall be in lawful money of the United States of America. This Note is subject to the following additional provisions:
